Journal
DRUG DISCOVERY TODAY
Volume 21, Issue 11, Pages 1787-1798Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2016.06.017
Keywords
-
Categories
Funding
- Arthritis Research UK [20400]
- University of Nottingham
- Versus Arthritis [20400] Funding Source: researchfish
Ask authors/readers for more resources
Since the sequencing of metazoan genomes began, it has become clear that the number of expressed proteins far exceeds the number of genes. It is now estimated that more than 98% of human genes give rise to multiple proteins through alternative pre-mRNA splicing. In this review, we highlight the known alternative splice variants of many channels, receptors, and growth factors that are important in nociception and pain. Recently, pharmacological control of alternative splicing has been proposed as potential therapy in cancer, wet age-related macular degeneration, retroviral infections, and pain. Thus, we also consider the effects that known splice variants of molecules key to nociception/pain have on nociceptive processing and/or analgesic action, and the potential for control of alternative pre-mRNA splicing as a novel analgesic strategy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available